Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

Bionano Symposium 2026 continues with Day 3: OGM Making its Mark in Constitutional Genetic Disorders on February 25, 2026, from 7:00-10:00 AM PT. Attendees may also explore scientific posters ...

Over the last decade, scientists have had a renewed interest in vaccines due to improved technology and biological discovery. Vaccines were previously deve | Immunology ...

Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 1:20 PM ESTCompany ParticipantsTom Frohlich ...

Critically, the study validated the bridging strategy using OncoHost's PROphet (R) platform--an AI-powered, plasma proteomics-based model designed to predict immunotherapy outcomes in patients with ...

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, ...

PRESS RELEASE AB SCIENCE ANNOUNCES THE IDENTIFICATION OF A PLASMA BIOMARKER THAT INDICATES THE ACTIVITY OF MASITINIB IN TREATING AMYOTROPHIC LATERAL SCLEROSIS, AND THAT IS CAPABLE OF IDENTIFYING ...

Three children still aviremic off ART provide hope that more cases are possible ...

(CR) rate among all six efficacy evaluable patientsFavorable safety profile with no Grade >3 CRS or ICANSPrior ...

The UPLC system was configured with an Acquity Premier Oligonucleotide C18 column (1.7 µm, 2.1 × 50 mm). The aqueous and ...

A team from the Institute of Materials Science of Seville (ICMS), a joint center of the Spanish National Research Council (CSIC) and the University of Seville (US), has developed a new hybrid device ...

Gilead Sciences and Arcellx have been collaborating on the multiple myeloma cell therapy anito-cel since 2022.